
Lung Cancer Screening with Low-Dose Chest Computed Tomography
Author(s) -
Yeon Wook Kim
Publication year - 2022
Publication title -
the korean journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 2289-0769
pISSN - 1738-9364
DOI - 10.3904/kjm.2022.97.1.42
Subject(s) - lung cancer screening , medicine , lung cancer , computed tomography , radiology , national lung screening trial , cancer , intensive care medicine , lung , population , randomized controlled trial , medical physics , oncology , surgery , environmental health
Early detection and treatment is important to reduce mortality from lung cancer. Based on the positive results of lung cancer-related mortality reduction from large randomized trials of low-dose chest computed tomography (LDCT)-based screening in high-risk populations, LDCT-based screening programs have been implemented in several countries including Republic of Korea. This review focus on the current evidence and state of the art of LDCT-based lung cancer screening, and further discuss the ongoing efforts to develop more efficient screening programs worldwide. This article includes recent updates on the identification of high-risk population eligible for screening and management for screen-detected nodules. Additionally, aspects on future research direction would be addressed.